Uncategorized - Blog

GlaxoSmithKline Canada invests $36 million in Mississauga

exterior20-20mississauga20manufacturing20facility203
exterior20-20mississauga20manufacturing20facility203

Earlier today, Mississauga Mayor Bonnie Crombie joined GlaxoSmithKline (GSK) Canada to make a $36 million announcement to further strengthen the company’s manufacturing facility in Mississauga. The funds will enable facility improvements, equipment purchases and enhanced manufacturing capabilities. GSK’s Mississauga facility will also soon begin producing Voltaren®, a consumer health brand in Canada for pain relief.…

Continue reading